Clinical Trials Sponsored by GeneOne Life Science, Inc.

Total 339 results

TriSalus Life Sciences, Inc.

Recruiting

Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

Locally Advanced Pancreatic Adenocarcinoma

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing Clinical Trial Experiences of Patients With Osteosarcoma

Osteosarcoma
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients

Diabetic Neuropathies | Diabetic Neuropathy Peripheral
Power Life Sciences Inc.

Not yet recruiting

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Amyotrophic Lateral Sclerosis | ALS
Power Life Sciences Inc.

Not yet recruiting

Neoadjuvant Immunotherapy in Advanced NSCLC

Lung Cancer, Non-small Cell

United States
Kezar Life Sciences, Inc.

Recruiting

KZR-261 in Subjects With Advanced Solid Malignancies

Advanced/Metastatic Solid Tumor

United States
Kezar Life Sciences, Inc.

Completed

A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (MISSION)

Systemic Lupus Erythematosus | Lupus Nephritis

United States, Australia, Mexico, Russian Federation, Colombia, Peru, Poland, Ukraine
TriSalus Life Sciences, Inc.

Active, not recruiting

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Hepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma

United States
ReAlta Life Sciences, Inc.

Completed

A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program

Healthy Volunteer

Canada
Afexa Life Sciences Inc

Completed

A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population

Upper Respiratory Tract Infections

Canada
Afexa Life Sciences Inc

Completed

LIP-01 in Hypercholesterolemia

Hypercholesterolemia

Canada, United States
Advanced Life Sciences, Inc.

Completed

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)

Pneumonia

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Participation Habits Among Plaque Psoriasis Patients

Plaque Psoriasis

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Patient Engagement Trends in TBI Clinical Research

TBI

United States
Power Life Sciences Inc.

Not yet recruiting

An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury

Traumatic Brain Injury

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Generalized Anxiety Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
ReAlta Life Sciences, Inc.

Recruiting

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research

Anxiety Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

Treatment Resistant Depression

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients

Diabetic Kidney Disease

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Trends in Renal Cell Carcinoma Studies

Renal Cell Carcinoma

United States
Power Life Sciences Inc.

Not yet recruiting

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Mantle Cell Lymphoma

United States
Power Life Sciences Inc.

Not yet recruiting

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Rhabdomyosarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer

Bladder Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Metastatic Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Cluster Headache Clinical Research

Cluster Headache

United States
Power Life Sciences Inc.

Not yet recruiting

Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

Squamous Cell Carcinoma

United States
Power Life Sciences Inc.

Not yet recruiting

Unveiling Patient Experiences in Testicular Cancer Clinical Trials

Testicular Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Study Experiences of Neuroblastoma Patients

Neuroblastoma

United States
Power Life Sciences Inc.

Not yet recruiting

Discovering Factors in Narcolepsy Patients' Clinical Research Experiences

Narcolepsy
Power Life Sciences Inc.

Not yet recruiting

Discovering Factors in the Clinical Trial Journey of Dementia Patients

Dementia
Power Life Sciences Inc.

Not yet recruiting

Assessing Factors in Tinnitus Patients' Clinical Study Experiences

Tinnitus
Power Life Sciences Inc.

Not yet recruiting

Appraising Medical Trial Experiences of Ovarian Cancer Patients

Ovarian Cancer
Power Life Sciences Inc.

Not yet recruiting

Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences

Cervical Cancer
Kezar Life Sciences, Inc.

Recruiting

A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Lupus Nephritis

United States, Korea, Republic of, Australia, Malaysia, Taiwan, South Africa, Singapore, United Kingdom, Puerto Rico, Croatia, India, Greece, Spain, Brazil, Philippines, Guatemala, Argentina, Portugal
Power Life Sciences Inc.

Not yet recruiting

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

Breast Cancer | Triple Negative Breast Cancer
Power Life Sciences Inc.

Not yet recruiting

Assessment of Rosacea Patients' Clinical Trial Experiences

Rosacea
Power Life Sciences Inc.

Not yet recruiting

Analyzing Clinical Trial Experiences of Colon Cancer Patients

Colon Cancer | Colon Disease
Power Life Sciences Inc.

Not yet recruiting

Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials

Bile Duct Cancer
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Trial Experiences of Patients With Migraine

Migraine | Migraine Disorders
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Trial Experiences of People With Leiomyosarcoma

Leiomyosarcoma
Power Life Sciences Inc.

Not yet recruiting

Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients

Multiple Sclerosis
Power Life Sciences Inc.

Not yet recruiting

Analyzing Orthopedic Patient Experience Patterns in Medical Trials

Orthopedic Disorder
Kezar Life Sciences, Inc.

Completed

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis (PRESIDIO)

Dermatomyositis | Polymyositis

United States, Czechia, Germany
Kezar Life Sciences, Inc.

Completed

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Dermatomyositis | Polymyositis

United States
ReAlta Life Sciences, Inc.

Withdrawn

A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure

COVID-19 | Acute Lung Injury | ALI

United States
Bioniche Life Sciences Inc.

Terminated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer (EMBARC-RF)

Carcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, Carcinoma

United States, Canada, Poland, Germany, Netherlands, United Kingdom
Bioniche Life Sciences Inc.

Withdrawn

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Bladder Cancer

United States
Alltech Life Sciences Inc.

Completed

Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress

Oxidative Stress

United States

Clinical Trials Sponsored by GeneOne Life Science, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations